Previous pulmonary infection impacts thoracoscopic procedure outcomes in patients with congenital lung malformations: a retrospective cohort study.
Complication
Congenital lung malformations
Conversion
Pulmonary infection
Thoracoscopic procedures
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
18 Apr 2023
18 Apr 2023
Historique:
received:
04
06
2022
accepted:
30
03
2023
medline:
20
4
2023
pubmed:
19
4
2023
entrez:
19
04
2023
Statut:
epublish
Résumé
Patients with congenital lung malformations (CLMs) are at high risk for developing pulmonary infection. Nonetheless, prophylactic surgical excision of asymptomatic CLMs is controversial and often delayed to symptoms occurring out of concern for potential operative risks. This study aims to evaluate the impact of previous pulmonary infection on the outcome of thoracoscopic procedures in CLMs patients. This was a retrospective cohort study of CLMs patients who received an elective operation at a tertiary care center from 2015 to 2019. Patients were divided into pulmonary infection (PI) or non-infection of pulmonary (NPI) groups according to the history of pulmonary infection. Propensity score matching was used to minimize the bias between groups. The primary outcome was conversion to thoracotomy. Postoperative outcomes were compared between patients with and without PI. We identified 464 patients, of whom 101 had a history of PI. Propensity score matching yielded a well-balanced cohort of 174 patients. PI was associated with higher conversion to thoracotomy (adjusted odds ratio = 8.7, 95% confidence interval, CI, 1.1-71.2, p = 0.039), blood loss (p = 0.044), and longer operative time (p < 0.001), chest tube placement time (p < 0.001), length of stay (p < 0.001), and postsurgical length of stay (p < 0.001). Elective operation in CLMs patients with a history of PI was associated with an increased risk of conversion to thoracotomy, operative time, blood loss, chest tube placement time, length of stay, and postsurgical length of stay. Elective thoracoscopic procedures in asymptomatic CLMs patients are safe and effective, and earlier surgical intervention may be warranted.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Patients with congenital lung malformations (CLMs) are at high risk for developing pulmonary infection. Nonetheless, prophylactic surgical excision of asymptomatic CLMs is controversial and often delayed to symptoms occurring out of concern for potential operative risks. This study aims to evaluate the impact of previous pulmonary infection on the outcome of thoracoscopic procedures in CLMs patients.
METHODS
METHODS
This was a retrospective cohort study of CLMs patients who received an elective operation at a tertiary care center from 2015 to 2019. Patients were divided into pulmonary infection (PI) or non-infection of pulmonary (NPI) groups according to the history of pulmonary infection. Propensity score matching was used to minimize the bias between groups. The primary outcome was conversion to thoracotomy. Postoperative outcomes were compared between patients with and without PI.
RESULTS
RESULTS
We identified 464 patients, of whom 101 had a history of PI. Propensity score matching yielded a well-balanced cohort of 174 patients. PI was associated with higher conversion to thoracotomy (adjusted odds ratio = 8.7, 95% confidence interval, CI, 1.1-71.2, p = 0.039), blood loss (p = 0.044), and longer operative time (p < 0.001), chest tube placement time (p < 0.001), length of stay (p < 0.001), and postsurgical length of stay (p < 0.001).
CONCLUSIONS
CONCLUSIONS
Elective operation in CLMs patients with a history of PI was associated with an increased risk of conversion to thoracotomy, operative time, blood loss, chest tube placement time, length of stay, and postsurgical length of stay. Elective thoracoscopic procedures in asymptomatic CLMs patients are safe and effective, and earlier surgical intervention may be warranted.
Identifiants
pubmed: 37072849
doi: 10.1186/s12931-023-02412-7
pii: 10.1186/s12931-023-02412-7
pmc: PMC10114450
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115Subventions
Organisme : the National Natural Science Foundation of China
ID : 31201095
Informations de copyright
© 2023. The Author(s).
Références
Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F372-F377
pubmed: 30049725
J Pediatr Surg. 1985 Oct;20(5):511-4
pubmed: 4057018
Pediatr Surg Int. 2017 Sep;33(9):971-975
pubmed: 28631022
J Pediatr Surg. 2018 Jun;53(6):1092-1097
pubmed: 29576400
J Laparoendosc Adv Surg Tech A. 2008 Jun;18(3):457-9
pubmed: 18503384
Semin Respir Crit Care Med. 2007 Jun;28(3):355-66
pubmed: 17562505
J Pediatr Surg. 2004 Mar;39(3):329-34; discussion 329-34
pubmed: 15017547
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Surg Endosc. 2022 Jan;36(1):711-717
pubmed: 33591448
J Pediatr Surg. 2018 May;53(5):1006-1009
pubmed: 29510872
Paediatr Respir Rev. 2004 Mar;5(1):59-68
pubmed: 15222956
Arch Dis Child. 2017 Sep;102(9):798-803
pubmed: 28584070
Pediatr Pulmonol. 2005 Dec;40(6):533-7
pubmed: 16200619
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Pediatr Dev Pathol. 2017 Sep-Oct;20(5):403-410
pubmed: 28812458
Lancet Child Adolesc Health. 2018 Apr;2(4):290-297
pubmed: 30169300
J Pediatr Surg. 2021 Nov;56(11):1982-1987
pubmed: 33573805
J Pediatr Surg. 2021 Dec;56(12):2148-2156
pubmed: 34030879
Pediatr Pulmonol. 2021 Jan;56(1):196-202
pubmed: 33111504
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620980267
pubmed: 33308023
Pediatr Surg Int. 2016 Apr;32(4):347-51
pubmed: 26661941